{"id":817297,"title":"Summary of RSV Vaccine Products in Late-Stage Development; Infographic, CCDR 46(4) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-02-13","captureTimestamp":"2026-02-13T02:09:15.165000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-2a-respiratory-syncytial-virus-vaccine-products.html","snippet":"RSV vaccine products Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 46–4: Respiratory syncytial virus (RSV) Date published: April 2, 2020 ISSN: 1481-8531 Subscribe to CCDR Submit your manuscript Information for authors About CCDR…","rawSnapshotUrl":"/api/snapshots/raw/817297","browseUrl":"https://replay.healtharchive.ca/job-7/20260213020915/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-2a-respiratory-syncytial-virus-vaccine-products.html#ha_snapshot=817297","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}